Figure 2 5 Clinical research progress and safety evaluation 5.1 Clinical efficacy studies Tirzepatide, a novel dual GLP-1 and GIP receptor agonist, has demonstrated remarkable efficacy in the management of type 2 diabetes and obesity, as evidenced by multiple high-quality clinical trials ( Importantly, tirzepatide may influence fat distribution, particularly by reducing visceral and cervical adiposity, which are closely associated with upper airway obstruction in OSAS
44 (10), e13425
Formulated with L-carnitine to support a healthy metabolism, plus prebiotics & postbiotics for optimal gut health, its a complete and balanced meal for daily well-being
So, the impact of l-Cys usage (as part of drugs or as dietary supplements) on human health is a controversial issue
Q: What is a Project Index Score
The medication is compounded by licensed 503A pharmacies, requires no insurance, and is HSA/FSA eligible